Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 04 symbols : Snynf save search
Sangamo Therapeutics Reports Recent Business and Clinical Highlights and Third Quarter 2021 Financial Results
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
SGMO | $0.5014 3.36% 730K
|
Health Technology
|
| O: 7.39%
H: 0.0%
C: 0.0%
financial results results
Verastem Oncology Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
Published: 2021-11-04 (Crawled : 01:00) - biospace.com/
VSTM | $9.85 -3.72% 130K
|
Health Technology
|
| O: -0.7%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
financial results results
Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2021
Published: 2021-11-04 (Crawled : 21:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
RLAY | $5.97 -2.29% 620K
|
Health Technology
|
| O: 0.03%
H: 1.35%
C: -2.39%
CLLS | $2.47 11K
|
Health Technology
|
| O: -5.54%
H: 7.67%
C: 5.43%
financial results results
The Talent Enterprise: The Thriving Index® is Now a British Psychological Society (BPS) Registered Test
Published: 2021-11-04 (Crawled : 14:15) - prnewswire.com
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
test
NodThera Announces Progress of NT-0796, a Novel NLRP3 Inflammasome Inhibitor, into a Phase 1 First-in-Human Study
Published: 2021-11-04 (Crawled : 14:00) - biospace.com/
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
phase 1 phase 2
Escient Pharmaceuticals Announces Data Presentations Highlighting the Preclinical and Clinical Development of EP547 at AASLD The Liver Meeting® Digital Experience 2021
Published: 2021-11-04 (Crawled : 13:00) - biospace.com/
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
presentation liver preclinical pre-clinical
Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update
Published: 2021-11-04 (Crawled : 13:00) - globenewswire.com
BMY | $48.89 1.22% 5.1M
|
Health Technology
|
| O: 1.37%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
REPL | $6.44 -7.6% 510K
|
Health Technology
|
| O: 4.09%
H: 2.47%
C: 0.85%
financial results results
Regeneron Reports Third Quarter 2021 Financial and Operating Results
Published: 2021-11-04 (Crawled : 11:00) - biospace.com/
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
REGN | $893.67 -0.04% 230K
|
Health Technology
|
| O: 3.07%
H: 0.39%
C: -1.46%
results
Gainers vs Losers
| 70% | 30% |
Top 10 Gainers
AGBA | News | $1.305 226.25% 130M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.